| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8827109 | Transplantation Proceedings | 2018 | 7 Pages |
Abstract
The findings of the present study revealed that more than one half of the study population were carrying the mutant allele CYP3A5*3(A6986G). CYP3A5 genetic polymorphism is one of the important factors in determining daily requirements for tacrolimus and in adjusting tacrolimus trough concentrations.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Y.Y. Htun, H.K. Swe, T.M. Saw,